Merck, Moderna skin cancer vaccine reduces disease’s recurrence, spread in large trial
- Posted on August 19, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
In brief
Generating AI summary…
Merck, Moderna skin cancer vaccine reduces disease’s recurrence, spread in large trial
Moderna shares soared on news of the interim results of the treatment, which combines a made-to-order mRNA vaccine with Merck’s Keytruda
